Annual Working Capital
$336.08 M
-$68.90 M-17.01%
December 31, 2023
Summary
- As of February 25, 2025, CTKB annual working capital is $336.08 million, with the most recent change of -$68.90 million (-17.01%) on December 31, 2023.
- During the last 3 years, CTKB annual working capital has risen by +$154.00 million (+84.57%).
- CTKB annual working capital is now -17.01% below its all-time high of $404.98 million, reached on December 31, 2022.
Performance
CTKB Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$327.39 M
-$4.31 M-1.30%
September 30, 2024
Summary
- As of February 25, 2025, CTKB quarterly working capital is $327.39 million, with the most recent change of -$4.31 million (-1.30%) on September 30, 2024.
- Over the past year, CTKB quarterly working capital has dropped by -$36.23 million (-9.96%).
- CTKB quarterly working capital is now -20.11% below its all-time high of $409.81 million, reached on September 30, 2021.
Performance
CTKB Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CTKB Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -10.0% |
| 3 y3 years | +84.6% | -11.8% |
| 5 y5 years | +619.3% | -11.8% |
CTKB Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.0% | at low | -19.2% | at low |
| 5 y | 5-year | -17.0% | +619.3% | -20.1% | +79.8% |
| alltime | all time | -17.0% | +619.3% | -20.1% | +79.8% |
Cytek Biosciences Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $327.39 M(-1.3%) |
| Jun 2024 | - | $331.70 M(-0.4%) |
| Mar 2024 | - | $333.08 M(-0.8%) |
| Dec 2023 | $336.08 M(-17.0%) | $335.83 M(-7.6%) |
| Sep 2023 | - | $363.62 M(-2.0%) |
| Jun 2023 | - | $371.23 M(+0.6%) |
| Mar 2023 | - | $369.11 M(-8.9%) |
| Dec 2022 | $404.98 M | $404.98 M(+0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $402.37 M(+0.4%) |
| Jun 2022 | - | $400.92 M(+1.2%) |
| Mar 2022 | - | $396.31 M(-0.6%) |
| Dec 2021 | $398.55 M(+118.9%) | $398.55 M(-2.7%) |
| Sep 2021 | - | $409.81 M(+117.1%) |
| Jun 2021 | - | $188.77 M(+2.2%) |
| Mar 2021 | - | $184.77 M(+1.5%) |
| Dec 2020 | $182.09 M(+289.7%) | $182.09 M |
| Dec 2019 | $46.73 M | - |
FAQ
- What is Cytek Biosciences annual working capital?
- What is the all time high annual working capital for Cytek Biosciences?
- What is Cytek Biosciences annual working capital year-on-year change?
- What is Cytek Biosciences quarterly working capital?
- What is the all time high quarterly working capital for Cytek Biosciences?
- What is Cytek Biosciences quarterly working capital year-on-year change?
What is Cytek Biosciences annual working capital?
The current annual working capital of CTKB is $336.08 M
What is the all time high annual working capital for Cytek Biosciences?
Cytek Biosciences all-time high annual working capital is $404.98 M
What is Cytek Biosciences annual working capital year-on-year change?
Over the past year, CTKB annual working capital has changed by -$68.90 M (-17.01%)
What is Cytek Biosciences quarterly working capital?
The current quarterly working capital of CTKB is $327.39 M
What is the all time high quarterly working capital for Cytek Biosciences?
Cytek Biosciences all-time high quarterly working capital is $409.81 M
What is Cytek Biosciences quarterly working capital year-on-year change?
Over the past year, CTKB quarterly working capital has changed by -$36.23 M (-9.96%)